ABBOTINDIA.BOBSE
Abbott India Limited
₹26700.00
ListedJan 3, 2000
SectorHealthcare
IndustryDrug Manufacturers — Specialty & Generic
CountryIndia
Employees3659
State-| CityMumbai| AddressGodrej BKC, Bandra-Kurla Complex| Phone91 22 5046 1000
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, neuro-psychiat, pain management, respiratory, hepatic, neuroscience, metabolics, gennext, and consumer care products. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Capital India Limited.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
37.6
?
Div. Rate
₹475.00
?
Div. Yield
1.75%
?
Payout Ratio
66.89%
?
Max Consec. Div. Years
25 years
?
Longest Consec. Div.
25 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.25
?
Div. Growth Rate
75.00%
?
Score
87

Dividend History

Historical dividend payments by ex-dividend date.

Jul 25, 2025
₹ 475.0000
Jul 19, 2024
₹ 410.0000
Jul 21, 2023
₹ 325.0000
Aug 2, 2022
₹ 275.0000
Jul 19, 2021
₹ 275.0000
Aug 28, 2020
₹ 250.0000
Aug 13, 2019
₹ 65.0000
Jul 10, 2018
₹ 55.0000
Jul 10, 2017
₹ 40.0000
Jul 8, 2016
₹ 35.0000
Jul 22, 2015
₹ 31.0000
Jul 23, 2014
₹ 23.0000
Apr 16, 2013
₹ 17.0000
May 4, 2012
₹ 17.0000
Apr 19, 2011
₹ 17.0000
Mar 3, 2010
₹ 17.0000
Mar 9, 2009
₹ 14.0000
Mar 28, 2008
₹ 17.5000
Apr 5, 2007
₹ 17.5000
Apr 21, 2006
₹ 17.5000
Apr 15, 2005
₹ 35.0000
Apr 16, 2004
₹ 35.0000
Apr 9, 2003
₹ 12.0000
Apr 8, 2002
₹ 10.0000
May 21, 2001
₹ 15.0000

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!